BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23991105)

  • 41. Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia.
    Mannowetz N; Würdinger R; Zippel A; Aumüller G; Wennemuth G
    Prostate; 2010 Sep; 70(12):1350-8. PubMed ID: 20623639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The expression and the functional roles of tissue factor and protease-activated receptor-2 on SW620 cells.
    Zhou H; Hu H; Shi W; Ling S; Wang T; Wang H
    Oncol Rep; 2008 Nov; 20(5):1069-76. PubMed ID: 18949403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA-ZDHHC8P1 promotes the progression and metastasis of colorectal cancer by targeting miR-34a.
    Li C; Liu T; Zhang Y; Li Q; Jin LK
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1476-1486. PubMed ID: 30840269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer.
    Yang H; Lin J; Jiang J; Ji J; Wang C; Zhang J
    Cell Cycle; 2020 Nov; 19(21):2939-2954. PubMed ID: 33044899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
    Ma Y; Qin H; Cui Y
    Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression.
    Huang CK; Aihara A; Iwagami Y; Yu T; Carlson R; Koga H; Kim M; Zou J; Casulli S; Wands JR
    Cancer Lett; 2016 Sep; 380(1):153-62. PubMed ID: 27364974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miR-18a promotes cell proliferation of esophageal squamous cell carcinoma cells by increasing cylin D1 via regulating PTEN-PI3K-AKT-mTOR signaling axis.
    Zhang W; Lei C; Fan J; Wang J
    Biochem Biophys Res Commun; 2016 Aug; 477(1):144-149. PubMed ID: 27291152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
    Ye J; Li L; Feng P; Wan J; Li J
    Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p.
    Li YY; Tao YW; Gao S; Li P; Zheng JM; Zhang SE; Liang J; Zhang Y
    EBioMedicine; 2018 Oct; 36():209-220. PubMed ID: 30243489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of miR-34a Effect on CCND1 mRNA Level and Sensitization of Breast Cancer Cell Lines to Paclitaxel.
    Irani S; Paknejad M; Soleimani M; Azam S
    Iran Biomed J; 2020 Nov; 24(6):361-9. PubMed ID: 32660221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B.
    Buddenkotte J; Stroh C; Engels IH; Moormann C; Shpacovitch VM; Seeliger S; Vergnolle N; Vestweber D; Luger TA; Schulze-Osthoff K; Steinhoff M
    J Invest Dermatol; 2005 Jan; 124(1):38-45. PubMed ID: 15654951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteinase-activated receptor-2-triggered prostaglandin E(2) release, but not cyclooxygenase-2 upregulation, requires activation of the phosphatidylinositol 3-kinase/Akt / nuclear factor-kappaB pathway in human alveolar epithelial cells.
    Moriyuki K; Sekiguchi F; Matsubara K; Nishikawa H; Kawabata A
    J Pharmacol Sci; 2009 Nov; 111(3):269-75. PubMed ID: 19881225
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostaglandin E(2) inhibits proteinase-activated receptor 2-signal transduction through regulation of receptor internalization.
    Komatsu H; Enjouji S; Ito A; Ohama T; Sato K
    J Vet Med Sci; 2013; 75(3):255-61. PubMed ID: 23064451
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.
    He X; Dong Y; Wu CW; Zhao Z; Ng SS; Chan FK; Sung JJ; Yu J
    Mol Med; 2013 Feb; 18(1):1491-8. PubMed ID: 23255074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activated protease receptor-2 induces GATA6 expression to promote survival in irradiated colon cancer cells.
    Cai WS; Shen F; Li JL; Feng Z; Wang YC; Xiao HQ; Xu B
    Arch Biochem Biophys; 2014 Aug; 555-556():28-32. PubMed ID: 24887481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long non-coding RNA HNF1A-AS1 mediated repression of miR-34a/SIRT1/p53 feedback loop promotes the metastatic progression of colon cancer by functioning as a competing endogenous RNA.
    Fang C; Qiu S; Sun F; Li W; Wang Z; Yue B; Wu X; Yan D
    Cancer Lett; 2017 Dec; 410():50-62. PubMed ID: 28943452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620.
    Hu L; Xia L; Zhou H; Wu B; Mu Y; Wu Y; Yan J
    Tumour Biol; 2013 Oct; 34(5):2573-81. PubMed ID: 23616010
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PAR1 and PAR2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiology.
    McCoy KL; Traynelis SF; Hepler JR
    Mol Pharmacol; 2010 Jun; 77(6):1005-15. PubMed ID: 20215560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostasin regulates iNOS and cyclin D1 expression by modulating protease-activated receptor-2 signaling in prostate epithelial cells.
    Chen LM; Hatfield ML; Fu YY; Chai KX
    Prostate; 2009 Dec; 69(16):1790-801. PubMed ID: 19670249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The RNA-binding protein SART3 promotes miR-34a biogenesis and G
    Sherman EJ; Mitchell DC; Garner AL
    J Biol Chem; 2019 Nov; 294(46):17188-17196. PubMed ID: 31619517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.